Nuzenio

Edgewise Therapeutics

Edgewise Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Evercore Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $55 - MoomooMoomoo · Fri, 07 Aug 2026 17:11:17 GMTEdgewise Therapeutics, Inc. (EWTX) stock price, news, quote and history - Yahoo Finance UKYahoo Finance UK · Fri, 07 Aug 2026 13:13:26 GMTEdgewise Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 14:38:36 GMTFMR LLC discloses 5.1% Edgewise Therapeutics (EWTX) holding in Schedule 13G - Stock TitanStock Titan · Thu, 06 Aug 2026 14:20:45 GMTEdgewise Therapeutics Q2 net loss widens to $57.3 million - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 12:16:00 GMTEdgewise Therapeutics reports Q2 net loss $57.3M, cash $460.7M; announces sale of sevasemten - TradingViewTradingView · Thu, 06 Aug 2026 12:13:01 GMTEdgewise Therapeutics (Nasdaq: EWTX) widens loss but nets $1,550 million Sevasemten Sale - Stock TitanStock Titan · Thu, 06 Aug 2026 12:06:48 GMTEdgewise Therapeutics Reports Second Quarter 2026 Financial Results - PR NewswirePR Newswire · Thu, 06 Aug 2026 12:00:00 GMT

Timeline

Fri, 07 Aug 2026 17:11:17 GMTEvercore Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $55 - Moomoo
Fri, 07 Aug 2026 13:13:26 GMTEdgewise Therapeutics, Inc. (EWTX) stock price, news, quote and history - Yahoo Finance UK
Thu, 06 Aug 2026 14:38:36 GMTEdgewise Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Thu, 06 Aug 2026 14:20:45 GMTFMR LLC discloses 5.1% Edgewise Therapeutics (EWTX) holding in Schedule 13G - Stock Titan
Thu, 06 Aug 2026 12:16:00 GMTEdgewise Therapeutics Q2 net loss widens to $57.3 million - Quiver Quantitative
Thu, 06 Aug 2026 12:13:01 GMTEdgewise Therapeutics reports Q2 net loss $57.3M, cash $460.7M; announces sale of sevasemten - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Edgewise Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.